Non‐coding RNAs in bone remodelling and bone metastasis: Mechanisms of action and translational relevance
- 18 August 2019
- journal article
- review article
- Published by Wiley in British Journal of Pharmacology
- Vol. 178 (9) , 1936-1954
Abstract
Bone metastases are frequent complications in patients with advanced cancer, which can be fatal or may rapidly impede the quality of life of patients. Current treatments for patients with bone metastases are palliative. Therefore, a better understanding of the molecular mechanisms that precede the overt development of skeletal lesions could lead to better therapeutic interventions. In this review, we present evidence that non‐coding RNAs (ncRNAs) such as long ncRNAs, microRNAs, and circular RNAs are emerging as master regulators of bone metastasis formation. We highlight potential opportunities for the therapeutic targeting of ncRNAs. Furthermore, we discuss the possibility that ncRNAs may be used as biomarkers in the context of bone metastases, which might provide insight for improving the response to current bone‐targeting therapies.LINKED ARTICLES: This article is part of a themed issue on The molecular pharmacology of bone and cancer‐related bone diseases. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v178.9/issuetocKeywords
Funding Information
- Deutsche Forschungsgemeinschaft (HE 5208/2‐3, TA1154/2‐1, TA1154/1‐1)
- University of Sheffield
- Université de Lyon
- Institut National de la Santé et de la Recherche Médicale (ASC17018CSA)
This publication has 148 references indexed in Scilit:
- A program of microRNAs controls osteogenic lineage progression by targeting transcription factor Runx2Proceedings of the National Academy of Sciences, 2011
- lncRNAs transactivate STAU1-mediated mRNA decay by duplexing with 3′ UTRs via Alu elementsNature, 2011
- Bone metastasis: mechanisms and therapeutic opportunitiesNature Reviews Endocrinology, 2011
- A network connecting Runx2, SATB2, and the miR-23a∼27a∼24-2 cluster regulates the osteoblast differentiation programProceedings of the National Academy of Sciences, 2010
- The widespread regulation of microRNA biogenesis, function and decayNature Reviews Genetics, 2010
- Dicer inactivation in osteoprogenitor cells compromises fetal survival and bone formation, while excision in differentiated osteoblasts increases bone mass in the adult mouseDevelopmental Biology, 2010
- Bone progenitor dysfunction induces myelodysplasia and secondary leukaemiaNature, 2010
- Dicer-dependent pathways regulate chondrocyte proliferation and differentiationProceedings of the National Academy of Sciences, 2008
- Endogenous human microRNAs that suppress breast cancer metastasisNature, 2008
- Functional Demarcation of Active and Silent Chromatin Domains in Human HOX Loci by Noncoding RNAsCell, 2007